Return to Clinical Trials Search Results

- A Phase 3, Randomized, Active-Comparator-Controlled Clinical Study to Evaluate the Safety and Efficacy of Bomedemstat (MK-3543) versus Hydroxyurea in Participants with Previously-Untreated Essential Thrombocythemia